Healthequity Stock Stock News Today

HQY -  USA Stock  

USD 59.23  0.22  0.37%

Healthequity Stock News module provides quick insight into current market opportunities from investing in Healthequity. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Healthequity stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please check Healthequity Hype Analysis, Healthequity Correlation and Healthequity Performance.
  
Refresh
Healthequity stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Healthequity daily returns and investor perception about the current pice of Healthequity as well as its diversification or hedging effects on your existing portfolios.
few days ago at www.marketscreener.com         
Vertex Announces 50 Million Commitment to Health Equity With Three Initial Grants - Marketscreener.c...
news
over a week ago at www.fiercehealthcare.com         
New legislation calls on CMMI to create model based on health equity - FierceHealthcare
news
over a week ago at www.fiercehealthcare.com         
Healthequity exotic insider transaction detected
news
over two weeks ago at www.macroaxis.com         
Healthequity exotic insider transaction detected
Macroaxis News
over three weeks ago at www.macroaxis.com         
Acquisition by Parker Stuart B of 1212 shares of Healthequity subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.axios.com         
FDA proposes ban on menthol cigarettes - Axios
news
over three weeks ago at finance.yahoo.com         
HIP HOP PUBLIC HEALTH LAUNCHES COMMUNITY IMMUNITY ALL ABOUT THE BOOSTER DURING WORLD IMMUNIZATION WE...
Yahoo News
over three weeks ago at finance.yahoo.com         
Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health Equ...
Yahoo News
over a month ago at www.macroaxis.com         
Acquisition by Stephen Neeleman of 9535 shares of Healthequity subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Payment of 1025 shares by Murdock Tyson D of Healthequity subject to Rule 16b-3
Macroaxis News
over a month ago at www.fiercehealthcare.com         
Weve always had the answers Put underserved patients in the drivers seat to improve outcomes, leader...
news
over a month ago at www.macroaxis.com         
Acquisition by Rosner Elimelech of 59480 shares of Healthequity subject to Rule 16b-3
Macroaxis News
over a month ago at www.marketscreener.com         
Payment of 591 shares by Murdock Tyson D of Healthequity subject to Rule 16b-3
news
over a month ago at finance.yahoo.com         
MacKenzie Scott Makes Transformative 12 Million Gift to National Medical Fellowships to Advance Heal...
Yahoo News
over two months ago at www.fool.com         
HealthEquity Q4 2022 Earnings Call Transcript - The Motley Fool
fool News
There is far too much social signal, news, headlines, and media speculation about Healthequity that is available to investors today. That information is available publicly through Healthequity media outlets and privately through word of mouth or via Healthequity internal channels. However, regardless of the origin, that massive amount of Healthequity data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Healthequity news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Healthequity relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Healthequity's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Healthequity alpha.

Healthequity Performance against DOW

 Price Growth (%)  
      Timeline 
1
HealthEquity Quality Firm, But Not Likely Worth The Price - ...03/01/2022
2
Earnings Outlook For HealthEquity - Benzinga - Benzinga03/21/2022
3
EPS Reported03/22/2022
4
Payment of 591 shares by Murdock Tyson D of Healthequity sub...03/31/2022
5
Acquisition by Rosner Elimelech of 59480 shares of Healthequ...04/01/2022
6
Payment of 1025 shares by Murdock Tyson D of Healthequity su...04/05/2022
7
Acquisition by Stephen Neeleman of 9535 shares of Healthequi...04/14/2022
8
HIP HOP PUBLIC HEALTH LAUNCHES COMMUNITY IMMUNITY ALL ABOUT ...04/26/2022
9
Acquisition by Parker Stuart B of 1212 shares of Healthequit...04/29/2022
10
Financial Statements05/02/2022
11
Healthequity exotic insider transaction detected05/04/2022
12
Financial Statements05/16/2022
13
Vertex Announces 50 Million Commitment to Health Equity With...05/17/2022
Please check Healthequity Hype Analysis, Healthequity Correlation and Healthequity Performance. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.